Phathom Pharmaceuticals Inc.
PHAT
|
|
| |
|
| Trading Volume | 42,912 |
|
|
16.12 - 6.21 |
| Market Cap Full | $ 0.9B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | 36.9% | -4.7% | 16.3% | -36.4% |
| Q2 | - | -32.4% | -1.9% | 100.6% |
| Q3 | - | -32.4% | 35.6% | -27.6% |
| Q4 | - | -32.4% | -55.9% | -10.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| -4.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -26.6 | 59.7 | -0.8 | -15.5 | 4.8 | 10.6 | 13.9 | 35.6 | - | - | - | -8.5 |
| 2023 | |||||||||||
| 6.3 | -28.3 | -16.6 | 49.9 | 9.9 | 21.8 | 6.2 | -5.4 | -27.9 | -10.3 | -24.8 | 30.6 |
| 2022 | |||||||||||
| -14.6 | 7.9 | -24.9 | -4.9 | -43.9 | 16.3 | 9.1 | -7.3 | 29.7 | -4.3 | -5.9 | 12.4 |
| 2021 | |||||||||||
| 16 | 14.3 | -14.2 | 1.4 | -8.2 | -4.2 | -4.9 | 10.6 | -9.8 | -26.7 | -23.8 | 9.6 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.9 | -1.1 | -1 |
| Q2 | -0.8 | -1.3 | -1 |
| Q3 | -0.8 | -1.3 | -1 |
| Q4 | 0 | -1.3 | -1 |
| A | -2.49 | -5.1 | -3.9 |